晨光生物(300138.SZ)：前三季度净利润同比预增344.05%至401.55%

Core Viewpoint - Morning Light Bio (300138.SZ) forecasts a significant increase in net profit for the first three quarters of 2025, indicating strong recovery and growth in its core business segments [1] Financial Performance - The net profit attributable to shareholders is expected to be between 278 million and 314 million yuan, representing a year-on-year growth of 344.05% to 401.55% [1] - The net profit after deducting non-recurring gains and losses is projected to be between 218 million and 254 million yuan, showing a substantial increase of 1,398.00% to 1,645.38% year-on-year [1] Business Segments - Revenue and gross profit from major plant extraction products have increased year-on-year, contributing to the recovery of profitability [1] - The cottonseed business has seen a market rebound, leading to a significant improvement in the operating environment and a turnaround from losses to profits [1]